MedPath

VYVGART

VYVGART

Approved
DIN Number

02541599

Drug Class

Human

Market Date

Nov 6, 2023

Company
HC

ARGENX BV

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02541599
AIG Number0165001001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Schedule D ,  Prescription
A
ATC Code
L04AA58 EFGARTIGIMOD ALFA
Product Specifications
Dosage FormSolution
Route of AdministrationIntravenous
AHFS Classification90:28.00
Health Canada Classification

ACTIVE INGREDIENTS (1)

EFGARTIGIMOD ALFAActive
Strength: 20 MG / ML
Monograph: EFGARTIGIMOD ALFA

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.